Abstract:Background Lymph node metastasis (LNM) is an important prognostic factor in endometrial cancer. Anomalous microRNAs (miRNAs) are associated with cell functions and are becoming a powerful tool to characterize malignant transformation and metastasis. The aim of this study was to construct a miRNA signature to predict LNM in endometrial endometrioid carcinoma (EEC). Method Candidate target miRNAs related to LNM in EEC were screened by three methods including differentially expressed miRNAs (DEmiRs), weighted gene co-expression network analysis (WGCNA), and decision tree algorithms. Samples were randomly divided into the training and validation cohorts. A miRNA signature was built using a logistic regression model and was evaluated by the area under the curve (AUC) of receiver operating characteristic curve (ROC) and decision curve analysis (DCA). We also conducted pathway enrichment analysis and miRNA–gene regulatory network to look for potential genes and pathways engaged in LNM progression. Survival analysis was performed, and the miRNAs were tested whether they expressed differently in another independent GEO database. Result Thirty-one candidate miRNAs were screened and a final 15-miRNA signature was constructed by logistic regression. The model showed good calibration in the training and validation cohorts, with AUC of 0.824 (95% CI, 0.739–0.912) and 0.821 (95% CI, 0.691–0.925), respectively. The DCA demonstrated the miRNA signature was clinically useful. Hub miRNAs in signature seemed to contribute to EEC progression via mitotic cell cycle, cellular protein modification process, and molecular function. MiR-34c was statistically significant in survival that a higher expression of miR-34c indicated a higher survival time. MiR-34c-3p, miR-34c-5p, and miR-34b-5p were expressed differentially in GSE75968. Conclusion The miRNA signature could work as a noninvasive method to detect LNM in EEC with a high prediction accuracy. In addition, miR-34c cluster may be a key biomarker referring LNM in endometrial cancer.

[Microrna Expression Signature Profile and Its Clinical Significance in Endometrioid Carcinoma].

Expression profiles of miRNA in typeⅠandⅡendometrial carcinoma

Expression Profile And Clinical Significance Of Micrornas In Papillary Thyroid Carcinoma

Down-regulation of miR-449a/b in Type Ⅱ Endometrial Carcinoma

Differential Expressions of Micrornas in Endometrioid Endometrial Adenocarcinoma

Upregulation of Microrna Mir-141-3p and Its Prospective Targets in Endometrial Carcinoma: a Comprehensive Study.

Expression profile of mammalian microRNAs in endometrioid adenocarcinoma.

Integrated Microrna and Mrna Transcriptome Sequencing Reveals the Potential Roles of Mirnas in Stage I Endometrioid Endometrial Carcinoma

Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients

Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas

Identification of Four Serum Micrornas from a Genome-Wide Serum Microrna Expression Profile As Potential Non-Invasive Biomarkers for Endometrioid Endometrial Cancer

Advances in MiRNAs Involved in Endometrial Carcinoma

miR-497-5p Decreased Expression Associated with High-Risk Endometrial Cancer

Mir-200A/mir-141 and Mir-205 Upregulation Might Be Associated with Hormone Receptor Status and Prognosis in Endometrial Carcinomas.

miRNA Expression Profiles in Ovarian Endometriosis and Two Types of Ovarian Cancer-Endometriosis-Associated Ovarian Cancer and High-Grade Ovarian Cancer

Expression Profiles of Endometrial Carcinoma by Integrative Analysis of TCGA Data.

Aberrant MicroRNA Expression in Patients With Endometrial Cancer

Construction of Mirna-Mrna Regulatory Network and Prognostic Signature in Endometrial Cancer.

Identification of an eleven-miRNA signature to predict the prognosis of endometrial cancer

Identification of a MicroRNA Signature Associated With Lymph Node Metastasis in Endometrial Endometrioid Cancer

Comparative Assessment of miR-185-5p and miR-191-5p Expression: From Normal Endometrium to High-Grade Endometrial Cancer